iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti–PD-1 therapy

体内 癌症研究 肿瘤细胞 医学 细胞毒性 生物 药理学 体外 化学 遗传学 生物化学
作者
Frank Cichocki,Ryan Bjordahl,Svetlana Gaidarova,Sajid Mahmood,Ramzey Abujarour,Hongbo Wang,Katie Tuininga,Martin Felices,Zachary Davis,Laura E. Bendzick,Raedun Clarke,Laurel Stokely,Paul Rogers,Moyar Ge,Megan Robinson,Betsy Rezner,David Robbins,Tom T. Lee,Dan S. Kaufman,Bruce R. Blazar
出处
期刊:Science Translational Medicine [American Association for the Advancement of Science]
卷期号:12 (568) 被引量:236
标识
DOI:10.1126/scitranslmed.aaz5618
摘要

The development of immunotherapeutic monoclonal antibodies targeting checkpoint inhibitory receptors, such as programmed cell death 1 (PD-1), or their ligands, such as PD-L1, has transformed the oncology landscape. However, durable tumor regression is limited to a minority of patients. Therefore, combining immunotherapies with those targeting checkpoint inhibitory receptors is a promising strategy to bolster antitumor responses and improve response rates. Natural killer (NK) cells have the potential to augment checkpoint inhibition therapies, such as PD-L1/PD-1 blockade, because NK cells mediate both direct tumor lysis and T cell activation and recruitment. However, sourcing donor-derived NK cells for adoptive cell therapy has been limited by both cell number and quality. Thus, we developed a robust and efficient manufacturing system for the differentiation and expansion of high-quality NK cells derived from induced pluripotent stem cells (iPSCs). iPSC-derived NK (iNK) cells produced inflammatory cytokines and exerted strong cytotoxicity against an array of hematologic and solid tumors. Furthermore, we showed that iNK cells recruit T cells and cooperate with T cells and anti-PD-1 antibody, further enhancing inflammatory cytokine production and tumor lysis. Because the iNK cell derivation process uses a renewable starting material and enables the manufacturing of large numbers of doses from a single manufacture, iNK cells represent an "off-the-shelf" source of cells for immunotherapy with the capacity to target tumors and engage the adaptive arm of the immune system to make a "cold" tumor "hot" by promoting the influx of activated T cells to augment checkpoint inhibitor therapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小小浪味仙完成签到,获得积分20
1秒前
琪子完成签到,获得积分20
2秒前
3秒前
FashionBoy的应助被Syanx_8采纳,获得10
3秒前
3秒前
帝休完成签到,获得积分10
4秒前
汉堡包的应助被Polymer采纳,获得10
4秒前
秋风的应助被阿玉艳采纳,获得20
5秒前
ZHW完成签到,获得积分10
5秒前
调皮颜发布了新的文献求助10
6秒前
7秒前
997完成签到,获得积分10
7秒前
hhh的应助被成就书芹采纳,获得10
8秒前
观赏热带鱼完成签到,获得积分10
9秒前
zy发布了新的文献求助10
9秒前
kkkk完成签到,获得积分10
10秒前
我是老大的应助被Lz采纳,获得10
10秒前
雨雨雨发布了新的文献求助10
10秒前
排骨焖面完成签到,获得积分10
11秒前
mikro完成签到 ,获得积分10
12秒前
11完成签到,获得积分10
12秒前
宫水三叶完成签到,获得积分20
12秒前
GTCC完成签到,获得积分10
12秒前
乐乐的应助被李优秀采纳,获得10
13秒前
14秒前
丘比特的应助被FFFFFF采纳,获得10
15秒前
成就书芹完成签到,获得积分10
16秒前
鹿鹿七完成签到 ,获得积分10
16秒前
ning10完成签到,获得积分20
16秒前
李健的小迷弟的应助被琪子采纳,获得20
16秒前
玻丽露露完成签到,获得积分10
16秒前
17秒前
17秒前
paofu完成签到,获得积分10
17秒前
情怀的应助被LFJ采纳,获得10
17秒前
18秒前
酷波er的应助被好天气采纳,获得10
19秒前
润泉完成签到,获得积分10
19秒前
搂猫睡觉的鱼完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186480
求助须知:如何正确求助?哪些是违规求助? 9574861
关于积分的说明 21838499
捐赠科研通 7784154
什么是DOI,文献DOI怎么找? 3434775
关于科研通互助平台的介绍 2559164
邀请新用户注册赠送积分活动 2481565